|
|
Volumn 377, Issue 9776, 2011, Pages 1465-
|
|
The three stages of Alzheimer's disease
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMYLOID BETA PROTEIN;
BIOLOGICAL MARKER;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
TRACER;
ALZHEIMER DISEASE;
AUTOPSY;
BEHAVIOR CHANGE;
CEREBROSPINAL FLUID;
COGNITIVE DEFECT;
CONCEPTUAL FRAMEWORK;
DEGENERATIVE DISEASE;
DEMOGRAPHY;
DIAGNOSTIC PROCEDURE;
DISEASE COURSE;
EDITORIAL;
FUNCTIONAL STATUS;
HIGH RISK PATIENT;
HUMAN;
INCIDENCE;
LIPID BLOOD LEVEL;
MENTAL DETERIORATION;
NEUROIMAGING;
NEUROLOGIC EXAMINATION;
PATHOPHYSIOLOGY;
PATIENT MONITORING;
PERSONALITY DISORDER;
POSITRON EMISSION TOMOGRAPHY;
PRACTICE GUIDELINE;
PREDICTIVE VALUE;
PRIORITY JOURNAL;
PUBLIC HEALTH;
RISK ASSESSMENT;
|
|
EID: 79955643152
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(11)60582-5 Document Type: Editorial |
|
Times cited : (11)
|
|
References (0)
|